In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies with a brief discussion about small cell transformation.

Guest: Triparna Sen, MD

Associate Professor

Director, Lung Cancer PDX Program,

Icahn School of Medicine at Mount Sinai

Guest:

Jacob Sands, MD

Assistant Professor of Medicine, Harvard Medical School

Lowe Cancer Center for Thoracic Oncology

Dana Farber Cancer Institute